BUD(BUD)
BUD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $64.87B | $67.43B | $69.96B | $74.42B | $76.72B |
| Low | $62.87B | $65.97B | $67.84B | $72.16B | $74.40B |
| High | $65.94B | $68.40B | $71.24B | $75.78B | $78.13B |
| EBITDA Avg | $24.62B | $25.59B | $26.55B | $28.24B | $29.12B |
| Low | $23.86B | $25.04B | $25.75B | $27.39B | $28.24B |
| High | $25.03B | $25.96B | $27.04B | $28.76B | $29.65B |
| EBIT Avg | $18.17B | $18.89B | $19.60B | $20.84B | $21.49B |
| Low | $17.61B | $18.48B | $19.00B | $20.21B | $20.84B |
| High | $18.47B | $19.16B | $19.95B | $21.23B | $21.88B |
| Net Income Avg | $8.93B | $9.77B | $10.79B | $12.06B | $14.35B |
| Low | $7.95B | $9.04B | $10.37B | $11.59B | $13.78B |
| High | $9.37B | $10.39B | $11.05B | $12.35B | $14.69B |
| EPS Avg | $4.50 | $4.93 | $5.44 | $6.08 | $7.23 |
| Low | $4.01 | $4.55 | $5.22 | $5.84 | $6.95 |
| High | $4.72 | $5.24 | $5.57 | $6.22 | $7.40 |
| Analysts (Rev / EPS) | 16 / 9 | 16 / 9 | 13 / 4 | 14 / 3 | 14 / 3 |
| Metric | Q4 2026 |
|---|---|
| Revenue Avg | $16.65B |
| Low | $16.58B |
| High | $16.73B |
| EBITDA Avg | $6.32B |
| Low | $6.29B |
| High | $6.35B |
| EBIT Avg | $4.66B |
| Low | $4.64B |
| High | $4.69B |
| Net Income Avg | $2.25B |
| Low | $2.14B |
| High | $2.37B |
| EPS Avg | $1.14 |
| Low | $1.08 |
| High | $1.20 |
| Analysts (Rev / EPS) | 5 / 4 |